Journal of Oral and Maxillofacial Pathology

INVITED REVIEW
Year
: 2022  |  Volume : 26  |  Issue : 3  |  Page : 300--306

Circulating biomarkers in oral cancer: Unravelling the mystery


Nilima Prakash, GL Pradeep 
 Department of Oral Pathology and Microbiology, MGV's KBH Dental College and Hospital, Nashik, Maharashtra, India

Correspondence Address:
Nilima Prakash
Department of Oral Pathology and Microbiology, MGV's KBH Dental College and Hospital, Nashik, Maharashtra
India

Oral squamous cell carcinoma (OSCC) is among the most common malignancies and a leading cause of death in developing countries. Late diagnosis and regional and/or distant metastasis worsen the prognosis of this condition. Despite the advances in diagnostic modalities and management strategies, there is little improvement in the 5-year survival rate. A deeper insight into the molecular events of various tumours has enabled the use of minimally invasive methods for monitoring disease progression, prognostication and treatment monitoring. Although studies in OSCC are preliminary, the use of liquid biopsies has opened new frontiers for the development of biomarkers that can serve as alternatives to conventional biopsies and imaging methods. Circulating biomarkers in blood allow for the real-time monitoring of tumour and therapeutic responses. This review aims to outline the promises and challenges of circulating biomarkers in OSCC with special emphasis on circulating tumour cells, circulating tumor DNA, and exosomes.


How to cite this article:
Prakash N, Pradeep G L. Circulating biomarkers in oral cancer: Unravelling the mystery.J Oral Maxillofac Pathol 2022;26:300-306


How to cite this URL:
Prakash N, Pradeep G L. Circulating biomarkers in oral cancer: Unravelling the mystery. J Oral Maxillofac Pathol [serial online] 2022 [cited 2022 Dec 9 ];26:300-306
Available from: https://www.jomfp.in/article.asp?issn=0973-029X;year=2022;volume=26;issue=3;spage=300;epage=306;aulast=Prakash;type=0